StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioLargo's total debt was $83.00K at Sep 30, 2025. For fiscal 2024 it was $66.00K, down 81.4% from the year before. The highest annual figure on record is $6.79M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$66.00K-81.4%
FY2023Dec 31, 2023$355.00K+5.3%
FY2022Dec 31, 2022$337.00K-31.8%
FY2021Dec 31, 2021$494.00K-71.2%
FY2020Dec 31, 2020$1.71M-64.0%
FY2019Dec 31, 2019$4.76M+36.4%
FY2018Dec 31, 2018$3.49M-48.6%
FY2017Dec 31, 2017$6.79M+16.8%
FY2016Dec 31, 2016$5.81M+79.0%
FY2015Dec 31, 2015$3.25M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$83.00K-66.8%
Q2 FY2025Jun 30, 2025$83.00K-76.3%
Q4 FY2024Dec 31, 2024$66.00K-81.4%
Q3 FY2024Sep 30, 2024$246.00K-31.5%
Q2 FY2024Jun 30, 2024$250.00K-31.5%
Q1 FY2024Mar 31, 2024$350.00K-4.9%
Q4 FY2023Dec 31, 2023$355.00K+5.3%
Q3 FY2023Sep 30, 2023$359.00K+7.8%
Q2 FY2023Jun 30, 2023$365.00K+11.3%
Q1 FY2023Mar 31, 2023$368.00K+13.6%
Q4 FY2022Dec 31, 2022$337.00K-31.8%
Q3 FY2022Sep 30, 2022$333.00K-31.9%
Q2 FY2022Jun 30, 2022$328.00K-32.4%
Q1 FY2022Mar 31, 2022$324.00K-65.1%
Q4 FY2021Dec 31, 2021$494.00K-71.2%
Q3 FY2021Sep 30, 2021$489.00K-83.1%
Q2 FY2021Jun 30, 2021$485.00K-90.3%
Q1 FY2021Mar 31, 2021$929.00K-82.6%
Q4 FY2020Dec 31, 2020$1.71M-64.0%
Q3 FY2020Sep 30, 2020$2.89M-59.9%
Q2 FY2020Jun 30, 2020$4.99M-1.0%
Q1 FY2020Mar 31, 2020$5.33M+25.9%
Q4 FY2019Dec 31, 2019$4.76M+36.4%
Q3 FY2019Sep 30, 2019$7.21M+217.0%
Q2 FY2019Jun 30, 2019$5.04M+204.8%
Q1 FY2019Mar 31, 2019$4.23M-40.9%
Q4 FY2018Dec 31, 2018$3.49M-48.6%
Q3 FY2018Sep 30, 2018$2.27M-64.0%
Q2 FY2018Jun 30, 2018$1.65M-69.9%
Q1 FY2018Mar 31, 2018$7.17M+24.4%
Q4 FY2017Dec 31, 2017$6.79M+16.8%
Q3 FY2017Sep 30, 2017$6.31M+15.8%
Q2 FY2017Jun 30, 2017$5.51M–
Q1 FY2017Mar 31, 2017$5.76M–
Q4 FY2016Dec 31, 2016$5.81M–
Q3 FY2016Sep 30, 2016$5.45M–

More BioLargo figures

See a number that looks wrong?